# New dermatitis clinical trials, last 30 days: 20 (2026)

Updated November 19, 2026.

20 new trials for dermatitis were first posted on ClinicalTrials.gov in the 30 days from October 20, 2026 to November 18, 2026, as read on November 19, 2026.

## The full list

New dermatitis clinical trials, last 30 days: 20 rows for $5, first posted from October 20, 2026 to November 18, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/new/dermatitis

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 20
- Recruiting or not yet: 17
- Read on: November 19, 2026

## Trials

The 20 newest of 20, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07944196 | Gut Microbiome Diversity in Adults With Inflammatory and Immune-Mediated Skin Diseases | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Observational | Recruiting | Atopic Dermatitis, Psoriasis, Hidradenitis Suppurativa (HS), Vitiligo - Macular Depigmentation, Alopecia Areata, Acne... | 694 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07944196) |
| November 17, 2026 | NCT07941388 | A Phase I Study of INT-1868 Tablets in Healthy Adult Participants (INT-1868-I101) | Innatus Therapeutics (Shanghai) Co., Ltd. | Phase 1 | Not yet recruiting | Atopic Dermatitis (AD) | 92 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07941388) |
| November 16, 2026 | NCT07938606 | MG-K10 in Pediatric Atopic Dermatitis (6-12 Years) | Shanghai Mabgeek Biotech.Co.Ltd | Phase 1/2 | Not yet recruiting | Atopic Dermatitis | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07938606) |
| November 16, 2026 | NCT07937592 | Study the Mechanism and Effectiveness of Probiotics on Atopic Dermatitis | National Cheng-Kung University Hospital | Not applicable | Enrolling by invitation | Atopic Dermatitis, Eczema | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07937592) |
| November 13, 2026 | NCT07934654 | The LITTLE OWLS Study (in German: "Kleine Eulen OWL"): Exploring the Early-life Microbiome Development and Physical and Mental Health... | Bielefeld University | Observational | Recruiting | Dermatitis, Atopic Dermatitis, Asthma (Diagnosis), Eczema, Allergy, Overweight , Obesity, Inflamatory Bowel Disease... | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07934654) |
| November 10, 2026 | NCT07929181 | Efficacy and Safety of Polisorb® MP in the Complex Therapy of Patients With Atopic Dermatitis | Polisorb Joint Stock Company | Phase 3 | Completed | Atopic Dermatitis | 161 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07929181) |
| November 6, 2026 | NCT07920809 | A Study of HSK60002 Tablets in Participants With Moderate-to-Severe Atopic Dermatitis | Haisco Pharmaceutical Group Co., Ltd. | Phase 1 | Not yet recruiting | Dermatitis Atopic | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07920809) |
| November 6, 2026 | NCT07920783 | A Phase I Study of GLR2053 Tablets in Chinese Healthy Adult Participants | Gan & Lee Pharmaceuticals. | Phase 1 | Not yet recruiting | Atopic Dermatitis | 124 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07920783) |
| November 5, 2026 | NCT07919899 | Pharmacokinetics, Immunogenicity and Safety of Subcutaneous Dupilumab and Berahyaluronidase Alfa (ALT-B4) Coformulation | Sanofi | Phase 3 | Not yet recruiting | Dermatitis Atopic | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919899) |
| November 5, 2026 | NCT07918586 | Localized Aeroallergen Exposure in Atopic Dermatitis | Fraunhofer-Institute of Toxicology and Experimental Medicine | Not applicable | Not yet recruiting | Atopic Dermatitis | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07918586) |
| November 5, 2026 | NCT07918560 | Cosmetic Efficacy Evaluation of Hydraporin AI Cream in Individuals With Atopic Dermatitis and Psoriasis | Brainfarma Industria Química e Farmacêutica S/A | Not applicable | Not yet recruiting | Atopic Dermatitis, Psoriasis | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07918560) |
| November 4, 2026 | NCT07916480 | Roflumilast Cream 0.3% for Moderate to Severe Atopic Dermatitis | Arcutis Biotherapeutics, Inc. | Phase 3 | Recruiting | Atopic Dermatitis, Atopic Dermatitis (AD), Atopic Dermatitis (Eczema) | 415 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07916480) |
| November 3, 2026 | NCT07914088 | A Study for AR100DP1 in Mild to Moderate Atopic Dermatitis | Arjil Pharmaceuticals LLC | Phase 2 | Recruiting | Dermatitis Atopic | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07914088) |
| November 2, 2026 | NCT07909967 | Observational Analytical Validation Study of the Replior ScratchSense | Replior AB | Observational | Recruiting | Atopic Dermatitis, Pruritus, Chronic Pruritus of Unknown Origin | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07909967) |
| October 30, 2026 | NCT07906886 | Topical Terbinafine Versus Hydrocortisone Combined With Oral Itraconazole for Seborrheic Dermatitis | Can Tho University of Medicine and Pharmacy | Phase 4 | Completed | Seborrheic Dermatitis | 76 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07906886) |
| October 29, 2026 | NCT07905547 | A Study to Investigate Dupixent/ Dupilumab in Adult Indian Participants With Moderate-to-severe Atopic Dermatitis | Sanofi | Phase 4 | Not yet recruiting | Atopic Dermatitis | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07905547) |
| October 29, 2026 | NCT07904689 | A Study of NOR-101 in Healthy Adults and Adults With Moderate-to-Severe Atopic Dermatitis | North Immunology Inc. | Phase 1 | Not yet recruiting | Atopic Dermatitis (AD) | 96 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07904689) |
| October 29, 2026 | NCT07904546 | ADBest TREAT Registry | Universitätsklinikum Hamburg-Eppendorf | Observational | Recruiting | Atopic Dermatitis | 5,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07904546) |
| October 26, 2026 | NCT07895615 | Phase II Clinical Study to Evaluate the Efficacy and Safety of LT-002-158 Tablets in Adult Patients With Moderate-to-Severe Atopic... | Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. | Phase 2 | Recruiting | Atopic Dermatitis (AD) | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07895615) |
| October 21, 2026 | NCT07887867 | A Study to Learn About the Study Medicine Abrocitinib in People With Severe Atopic Dermatitis Who Have Switched From Other Therapies | Pfizer | Observational | Not yet recruiting | Dermatitis, Atopic | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07887867) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 4 |
| Phase 1/2 | 1 |
| Phase 2 | 2 |
| Phase 3 | 3 |
| Phase 4 | 2 |
| Not applicable | 3 |
| Observational | 5 |

## Sponsors posting most

| Sponsor | Trials |
| --- | --- |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 2 |
| Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 1 |
| Innatus Therapeutics (Shanghai) Co., Ltd. | 1 |
| Shanghai Mabgeek Biotech.Co.Ltd | 1 |
| National Cheng-Kung University Hospital | 1 |
| Bielefeld University | 1 |
| Polisorb Joint Stock Company | 1 |
| [Haisco Pharmaceutical Group Co., Ltd.](https://specstream.ai/data/clinical-trials/company/haisco-pharmaceutical-group-co-ltd) | 1 |
| [Gan & Lee Pharmaceuticals.](https://specstream.ai/data/clinical-trials/company/gan-and-lee-pharmaceuticals) | 1 |
| Fraunhofer-Institute of Toxicology and Experimental Medicine | 1 |
| Brainfarma Industria Química e Farmacêutica S/A | 1 |
| [Arcutis Biotherapeutics, Inc.](https://specstream.ai/data/clinical-trials/company/arcutis-biotherapeutics-inc) | 1 |
| Arjil Pharmaceuticals LLC | 1 |
| Replior AB | 1 |
| Can Tho University of Medicine and Pharmacy | 1 |
| North Immunology Inc. | 1 |
| Universitätsklinikum Hamburg-Eppendorf | 1 |
| Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. | 1 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Clinical laboratories in the United States](https://specstream.ai/data/businesses/clinical-laboratories/united-states)
- [Greek restaurants in the United States](https://specstream.ai/data/businesses/greek-restaurants/united-states)
- [Office supply stores in the United States](https://specstream.ai/data/businesses/office-supply-stores/united-states)
- [Structural engineering firms in the United States](https://specstream.ai/data/businesses/structural-engineering-firms/united-states)
- [B2B oil and gas exploration and development companies in the United States](https://specstream.ai/data/businesses/b2b-oil-and-gas-exploration-and-development-companies/united-states)
- [Ear, nose and throat clinics in the United States](https://specstream.ai/data/businesses/ear-nose-and-throat-clinics/united-states)
